We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$91.3B
AUM Growth
+$6.27B
Cap. Flow
+$3.06B
Cap. Flow %
3.35%
Top 10 Hldgs %
13.7%
Holding
3,123
New
88
Increased
2,252
Reduced
349
Closed
49

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$99.8M
2
MSFT icon
Microsoft
MSFT
+$82.2M
3
PFE icon
Pfizer
PFE
+$61.6M
4
CL icon
Colgate-Palmolive
CL
+$60M
5
AMZN icon
Amazon
AMZN
+$59.9M

Sector Composition

Rank Sector Weight
1 Financials 14.91%
2 Technology 14.06%
3 Healthcare 12.49%
4 Industrials 11.09%
5 Consumer Discretionary 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEOS
3026
DELISTED
Neos Therapeutics, Inc
NEOS
$126K ﹤0.01%
21,500
USAK
3027
DELISTED
USA Truck Inc
USAK
$124K ﹤0.01%
14,200
TNDM icon
3028
Tandem Diabetes Care
TNDM
$1.38B
$123K ﹤0.01%
5,677
+324
+6% +$12.5K
TTNP
3029
DELISTED
Titan Pharmaceuticals
TTNP
$121K ﹤0.01%
8
AXSM icon
3030
Axsome Therapeutics
AXSM
$10.9B
$120K ﹤0.01%
17,700
CBIO
3031
Crescent Biopharma
CBIO
$552M
$120K ﹤0.01%
196
UONEK icon
3032
Urban One Class D
UONEK
$22.8M
$120K ﹤0.01%
4,120
LWAY icon
3033
Lifeway Foods
LWAY
$452M
$117K ﹤0.01%
10,100
TTOO
3034
DELISTED
T2 Biosystems, Inc
TTOO
$114K ﹤0.01%
4
XMAX
3035
XMAX Inc
XMAX
$558M
$111K ﹤0.01%
+2,288
New +$174K
ARGS
3036
DELISTED
Argos Therapeutics, Inc.
ARGS
$109K ﹤0.01%
1,110
GSOL
3037
DELISTED
Global Sources Ltd
GSOL
$107K ﹤0.01%
12,000
TSQ icon
3038
Townsquare Media
TSQ
$109M
$106K ﹤0.01%
10,100
DCOY
3039
Decoy Therapeutics
DCOY
$2.31M
0
CRK icon
3040
Comstock Resources
CRK
$3.94B
$101K ﹤0.01%
10,160
KDMN
3041
DELISTED
Kadmon Holdings, Inc.
KDMN
$99K ﹤0.01%
+18,500
New +$104K
VSLR
3042
DELISTED
VIVINT SOLAR, INC.
VSLR
$99K ﹤0.01%
38,455
+1,078
+3% +$3.21K
LPCN icon
3043
Lipocine
LPCN
$17.4M
$97K ﹤0.01%
1,535
AGFS
3044
DELISTED
AgroFresh Solutions Inc
AGFS
$93K ﹤0.01%
35,000
VANI icon
3045
Vivani Medical
VANI
$115M
$92K ﹤0.01%
1,944
+128
+7% +$7.31K
INFI
3046
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$92K ﹤0.01%
67,500
TOVX icon
3047
Theriva Biologics
TOVX
$10.2M
$91K ﹤0.01%
13
ABCD
3048
DELISTED
Cambium Learning Group, Inc.
ABCD
$90K ﹤0.01%
18,000
IMDZ
3049
DELISTED
Immune Design Corp.
IMDZ
$90K ﹤0.01%
16,243
DALN
3050
DELISTED
DallasNews
DALN
$89K ﹤0.01%
3,495

Similar funds

Charles Schwab's Q4 2016 Portfolio in Review

As of Q4 2016, Charles Schwab held 3,123 positions worth $91.3B, up 7.4% from $85.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $3.06B of net new capital in Q4 2016, opening 88 new positions and adding to 2,252 existing holdings. Its largest new stake was Howmet Aerospace: 1,721,382 shares worth $24.5M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Huntington Ingalls Industries, an estimated $51.6M trimmed.

  • Charles Schwab's largest Q4 2016 buy was Howmet Aerospace: 1,721,382 shares worth $24.5M.
  • Charles Schwab added most to Apple in Q4 2016, an estimated $99.8M increase.
  • Charles Schwab's biggest Q4 2016 reduction was Huntington Ingalls Industries, cutting an estimated $51.6M.
  • Charles Schwab fully exited DONNELLEY R R & SONS CO in Q4 2016, selling an estimated $64.4M.
  • Charles Schwab's ten largest holdings make up 14% of its $91.3B portfolio in Q4 2016.
  • Charles Schwab opened 88 new positions and closed 49 in Q4 2016.
  • Charles Schwab's portfolio value rose 7.4% quarter-over-quarter to $91.3B.

Based on Charles Schwab's 13F filing for Q4 2016, filed 13 Feb 2017.